Αποτελέσματα Αναζήτησης
1 Ιουλ 2020 · For this patient with clinical stage T2N0 cancer, the standard approach for triple-negative breast cancer before the Covid-19 pandemic would have involved neoadjuvant chemotherapy with deferred...
- Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
Evolution and prognostic significance of HER-2 conversion...
- 20-Year Risks of Breast-Cancer Recurrence After Stopping Endocrine Therapy at 5 Years
During the study period from 5 to 20 years, the absolute...
- Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
Prediction of Oncotype DX Recurrence Score Based on...
- Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
The RASTER (Microarray Prognostics in Breast Cancer) study...
- Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
1 Ιαν 2011 · PDF | In this case study, a women aged 40 was diagnosed with Metastatic breast cancer. Metastatic breast cancer is a complex multi-stage disease... | Find, read and cite all the research you...
1 Δεκ 2019 · PDF | Breast cancer is the most frequent malignancy in women worldwide and is curable in ~70-80% of patients with early-stage, non-metastatic disease.... | Find, read and cite all the research...
25 Σεπ 2019 · Case 30-2019: A 65-Year-Old Woman with Lung Cancer and Chest Pain. Authors: Timothy E. Guiney, M.D., Mathew S. Lopes, M.D., Mannudeep K. Kalra, M.D., Meghan J. Mooradian, M.D., Tomas G. Neilan,...
5 Ιουν 2024 · A 45-year-old woman was evaluated in the oncology clinic of the hospital because of metastatic triple-negative breast cancer that had progressed despite chemotherapy. Management decisions were...
28 Μαΐ 2021 · Free access. Symptoms and Survivorship. May 28, 2021. Long-term quality of life of cancer survivors: A case-control study. Authors: Joaquin Ponce-Zepeda and Tuyen Hoang Authors Info & Affiliations. Publication: Journal of Clinical Oncology. Volume 39, Number 15_suppl. https://doi.org/10.1200/JCO.2021.39.15_suppl.12077. Abstract. 12077.
5 Απρ 2011 · This Case Study describes a patient with breast cancer who was treated with capecitabine and experienced a severe adverse event when treated with brivudin for a herpes infection.